Insulin: A Growth Hormone and Potential Oncogene.


Journal

Pediatric endocrinology reviews : PER
ISSN: 1565-4753
Titre abrégé: Pediatr Endocrinol Rev
Pays: Israel
ID NLM: 101202124

Informations de publication

Date de publication:
Mar 2020
Historique:
entrez: 26 3 2020
pubmed: 26 3 2020
medline: 6 5 2020
Statut: ppublish

Résumé

Both in vitro and in vivo experimental studies proved that insulin has an important anabolic role. This physiological function of insulin is reflected in its well documented involvement in protein metabolism and in acceleration of cell proliferation. Support for a growth promoting action of insulin is further provided by clinical studies that revealed that children with hypoinsulinemia have a decreased growth rate whereas, on the other hand, children with hyperinsulinemia have an accelerated growth. While it was initially assumed that the growth activities of insulin are facilitated via cross-talk with the closely related insulin-like growth factor-1 receptor (IGF-1R), it is now clear that the vast majority of these activities are mediated via direct interaction with the insulin receptor (IR). The present article provides an overview of the growth and proliferative actions of insulin, with an emphasis on a number of pathological conditions, including cancer.

Identifiants

pubmed: 32208563
doi: 10.17458/per.vol17.2020.lw.insulinghpotentialoncogene
doi:

Substances chimiques

Insulin 0
Human Growth Hormone 12629-01-5
Insulin-Like Growth Factor I 67763-96-6
Growth Hormone 9002-72-6
Receptor, IGF Type 1 EC 2.7.10.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-197

Informations de copyright

Copyright© of YS Medical Media ltd.

Auteurs

Zvi Laron (Z)

Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center, Petah Tikva, Israel, E-mail: laronz@clalit.org.il.

Haim Werner (H)

Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH